Plain-English translation of NCT05387863 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new online decision aid — a personalized tool designed to help patients with small kidney tumors make informed treatment choices. The tool will show you the benefits and risks of different treatment options based on your own values and health situation. Researchers want to understand how patients decide on treatment and use that knowledge to build a better tool that puts patients in the center of the decision-making process.
Right now, patients with small kidney tumors face several treatment options, but there isn't a standard way to help them understand which option is best for their individual situation. This research aims to fill that gap by creating a personalized tool that communicates real risks and benefits in a way that makes sense to each patient.
You likely qualify if…
You likely don't qualify if…
You would be assigned to either use a new online decision-making tool or receive standard printed information about kidney tumor treatment options. You would likely complete this during or around your regular urology appointments at NYU. The study involves 40 patients total and focuses on understanding your preferences and how well the decision aid helps you think through your treatment options.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
NYU Langone Health
Enrollment target
~40 participants
Started
September 2022
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Stella Kang, MD
NYU Langone Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.